Free Trial

3 reasons 2024 Moderna shareholders may party like it's 2021

Key Points

  • Moderna has a dominant grasp on the Covid vaccine market — and a significant revenue contributor for years to come.
  • Moderna’s second commercialized product is expected to be the RSV vaccine MRNA-1345, a catalyst Moderna shareholders have long awaited.
  • Oppenheimer analyst Hartaj Singh kicked off the new year by upgrading MRNA to a Buy.
  • 5 stocks we like better than Moderna.

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should you invest $1,000 in Moderna right now?

Before you consider Moderna, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moderna wasn't on the list.

While Moderna currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Moderna (MRNA)
4.2664 of 5 stars
$39.39-0.4%N/A-6.77Hold$79.50
Merck & Co., Inc. (MRK)
4.989 of 5 stars
$98.05-1.5%3.14%20.56Moderate Buy$127.13
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines